Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) was the recipient of a large increase in short interest in July. As of July 15th, there was short interest totaling 125,563 shares, an increase of 143.6% from the June 30th total of 51,538 shares. Based on an average daily trading volume, of 209,024 shares, the days-to-cover ratio is presently 0.6 days.
Analysts Set New Price Targets
Separately, Zacks Research cut Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.
View Our Latest Stock Report on SMMNY
Siemens Healthineers Stock Up 2.0%
Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.02. The company had revenue of $6.68 billion during the quarter, compared to analyst estimates of $6.96 billion.
Siemens Healthineers Company Profile
Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.
The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.
Further Reading
- Five stocks we like better than Siemens Healthineers
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
